Mutational signatures in Helicobacter pylori-induced gastric cancer: lessons from new sequencing technologies

Gastroenterology. 2014 Aug;147(2):267-9. doi: 10.1053/j.gastro.2014.06.019. Epub 2014 Jun 25.

Authors

Sarah Derks¹, Adam J Bass²

Affiliations

¹ Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
² Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts and Cancer Program, The Broad Institute of MIT and Harvard, Cambridge, Massachusetts. Electronic address: adam_bass@dfci.harvard.edu.

PMID: 24973679
DOI: 10.1053/j.gastro.2014.06.019

No abstract available

Publication types

Editorial
Comment

MeSH terms

Animals
Cell Transformation, Neoplastic / genetics*
Gastric Mucosa / microbiology*
Gastritis / genetics*
Helicobacter Infections / genetics*
Helicobacter pylori / pathogenicity*
Humans
Mutation*
Precancerous Conditions / genetics*
Stomach Neoplasms / genetics*
Tumor Suppressor Protein p53 / genetics*

Substances

TP53 protein, human
Tumor Suppressor Protein p53